Shopping Cart
Remove All
Your shopping cart is currently empty
P2Y1 antagonist 2 (Compound 19) is a P2Y1 receptor antagonist with an IC50 of 0.49 μM. It exhibits significant anti-platelet aggregation activity by inhibiting the P2Y1 receptor. Additionally, this compound elevates nuclear Nrf2 protein levels, showing neuroprotective effects against oxidative stress damage. P2Y1 antagonist 2 effectively reduces cerebral infarction size and improves neurological function, making it useful for ischemic stroke research.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | P2Y1 antagonist 2 (Compound 19) is a P2Y1 receptor antagonist with an IC50 of 0.49 μM. It exhibits significant anti-platelet aggregation activity by inhibiting the P2Y1 receptor. Additionally, this compound elevates nuclear Nrf2 protein levels, showing neuroprotective effects against oxidative stress damage. P2Y1 antagonist 2 effectively reduces cerebral infarction size and improves neurological function, making it useful for ischemic stroke research. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.